Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 1CNS 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Filgrastim 9Cytarabine 7Etoposide 5Cefepime 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Levofloxacin 3Idarubicin 3Daunorubicin 3Cyclosporine 3Ciprofloxacin 3Caspofungin 3pegfilgrastim 2liposomal amphotericin B 2Thioguanine 2Radiotherapy 2Methotrexate 2Meropenem 2Itraconazole 2Cyclophosphamide 2Ceftazidime 2Amsacrine 2Amoxicillin-Potassium Clavulanate Combination 2sargramostim 1posaconazole 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Amikacin × Other hematologic neoplasm × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡